MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals, Biotechnology & Technology _ Liver
Mursla Bio*
Organization & Developments: Mursla Bio
Parents
Mursla Bio*
Children
*Mursla Bio’s Dynamic Biopsy technology combines the accuracy and disease sub-typing capabilities of tissue biopsies with the ease of liquid biopsy sample collection, providing a non-invasive intervention with comprehensive biological insights
*Non-invasive diagnostic platform for early detection of cancer.
*Platform applies omics analysis and organ-specific vesicle isolation from biofluids for precise targeting and AI enabled disease biomarker identification
2025: Mursla Bio receives FDA Breakthrough Device Designation for EvoLiver™ test
Jumps
Finance & Acquisition: Mursla Bio
Key People: Mursla Bio